JP2025511288A5 - - Google Patents
Info
- Publication number
- JP2025511288A5 JP2025511288A5 JP2024558263A JP2024558263A JP2025511288A5 JP 2025511288 A5 JP2025511288 A5 JP 2025511288A5 JP 2024558263 A JP2024558263 A JP 2024558263A JP 2024558263 A JP2024558263 A JP 2024558263A JP 2025511288 A5 JP2025511288 A5 JP 2025511288A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- sequence shown
- chain variable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210343374.8A CN116925222A (zh) | 2022-04-02 | 2022-04-02 | 抗pvrig抗体、其药物组合物及用途 |
| CN202210343374.8 | 2022-04-02 | ||
| PCT/CN2023/085357 WO2023186063A1 (zh) | 2022-04-02 | 2023-03-31 | 抗pvrig抗体、其药物组合物及用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025511288A JP2025511288A (ja) | 2025-04-15 |
| JP2025511288A5 true JP2025511288A5 (https=) | 2026-04-06 |
Family
ID=88199482
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024558263A Pending JP2025511288A (ja) | 2022-04-02 | 2023-03-31 | 抗ｐｖｒｉｇ抗体、その医薬組成物及びその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250223353A1 (https=) |
| EP (1) | EP4506360A4 (https=) |
| JP (1) | JP2025511288A (https=) |
| KR (1) | KR20240168451A (https=) |
| CN (2) | CN116925222A (https=) |
| AU (1) | AU2023243878A1 (https=) |
| CA (1) | CA3256036A1 (https=) |
| WO (1) | WO2023186063A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116135884A (zh) * | 2021-11-17 | 2023-05-19 | 普米斯生物技术(珠海)有限公司 | 抗tigit-抗pd-l1双特异性抗体、其药物组合物及用途 |
| CN120025447A (zh) * | 2023-11-23 | 2025-05-23 | 广东菲鹏制药股份有限公司 | 抗人pvrig抗体及其应用 |
| CN120005023B (zh) * | 2023-12-22 | 2025-12-26 | 华润生物医药有限公司 | 抗pvrig抗体及其用途 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US8877688B2 (en) | 2007-09-14 | 2014-11-04 | Adimab, Llc | Rationally designed, synthetic antibody libraries and uses therefor |
| EP3124497B1 (en) | 2007-09-14 | 2020-04-15 | Adimab, LLC | Rationally designed, synthetic antibody libraries and uses therefor |
| KR102318383B1 (ko) | 2010-07-16 | 2021-10-27 | 아디맵 엘엘씨 | 항체 라이브러리 |
| KR102236367B1 (ko) | 2013-07-26 | 2021-04-05 | 삼성전자주식회사 | DARPin을 포함하는 이중 특이 키메라 단백질 |
| CA2942546C (en) | 2014-03-17 | 2022-11-22 | Mitsubishi Tanabe Pharma Corporation | Antibody-fynomer conjugates |
| DK3653221T5 (da) | 2015-02-19 | 2024-08-26 | Compugen Ltd | Anti-pvrig-antistoffer og anvendelsesfremgangsmåder |
| US10407484B2 (en) * | 2015-09-02 | 2019-09-10 | The Regents Of The University Of Colorado, A Body Corporate | Compositions and methods for modulating T-cell mediated immune response |
| JP7348072B2 (ja) * | 2017-06-01 | 2023-09-20 | コンピュジェン リミテッド | 三重併用抗体療法 |
| KR20210016448A (ko) * | 2018-06-01 | 2021-02-15 | 컴퓨젠 엘티디. | 항-pvrig/항-tigit 이중특이적 항체 및 사용 방법 |
| MX2021000745A (es) * | 2018-07-20 | 2021-03-26 | Surface Oncology Inc | Composiciones anti-cd112r y metodos. |
| CN113164766B (zh) | 2018-10-23 | 2025-02-25 | 供石公司 | RGMc选择性抑制剂及其用途 |
| CA3170025A1 (en) * | 2020-03-13 | 2021-09-16 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Pvrig binding protein and its medical uses |
-
2022
- 2022-04-02 CN CN202210343374.8A patent/CN116925222A/zh active Pending
-
2023
- 2023-03-31 WO PCT/CN2023/085357 patent/WO2023186063A1/zh not_active Ceased
- 2023-03-31 JP JP2024558263A patent/JP2025511288A/ja active Pending
- 2023-03-31 EP EP23778428.5A patent/EP4506360A4/en active Pending
- 2023-03-31 CN CN202380031274.4A patent/CN118946588A/zh active Pending
- 2023-03-31 KR KR1020247036668A patent/KR20240168451A/ko active Pending
- 2023-03-31 CA CA3256036A patent/CA3256036A1/en active Pending
- 2023-03-31 AU AU2023243878A patent/AU2023243878A1/en active Pending
- 2023-03-31 US US18/852,907 patent/US20250223353A1/en active Pending